Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plans (Tables)

v3.21.1
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock Option Activity

A summary of option activities under the 2005 Plan and 2017 Plan during the three months ended March 31, 2021 is as follows:

 

 

 

Number
of Options
Outstanding

 

 

Weighted
Average
Exercise
Price

 

Outstanding as of December 31, 2020

 

 

813,242

 

 

$

24.58

 

Granted

 

 

65,132

 

 

$

38.46

 

Exercised

 

 

(60,600

)

 

$

3.53

 

Canceled

 

 

(3,234

)

 

$

40.11

 

Outstanding as of March 31, 2021

 

 

814,540

 

 

$

27.20

 

Schedule of Unvested Restricted Stock Units Awards Activity

A summary of restricted stock unit ("RSU") activities under the 2017 Plan during the three months ended March 31, 2021 is as follows:

 

 

 

Number of Restricted Stock Units

 

 

Weighted
Average
Grant Date Fair Value per RSU

 

 

Nonvested at December 31, 2020

 

 

141,508

 

 

$

29.67

 

 

Granted

 

 

64,408

 

 

$

37.26

 

 

Vested

 

 

(24,332

)

 

$

22.21

 

 

Nonvested at March 31, 2021

 

 

181,584

 

 

$

33.36

 

 

 

Schedule of Stock-Based Compensation Expense Recorded in Condensed Consolidated Statements of Operations

Total stock-based compensation expense associated with the 2005 Plan, 2017 Plan and 2017 ESPP is recorded in the condensed consolidated statements of operations and was allocated as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Cost of revenues

 

$

392

 

 

$

217

 

Sales and marketing

 

 

371

 

 

 

256

 

Research and development

 

 

181

 

 

 

102

 

General and administrative

 

 

431

 

 

 

312

 

Total

 

$

1,375

 

 

$

887